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Serologic and molecular
characterization of the B(A) blood
group in the Chinese population
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B(A) phenotype individuals have normal B antigen and a small
amount of A antigen on the RBCs with anti-A in the plasma. Some
highly potent monoclonal anti-A reagents are capable of agglu-
tinating B(A) RBCs,which therefore usually results in a discrepancy
between RBC and plasma ABO grouping. To date, five B(A) alleles
(ABO*B(A)01, B(A)02, B(A)03, B(A)04, and B(A)05) have been
defined by nucleotide sequences. To get a more complete picture
of B(A) phenotypes found in the Chinese population and resolve
blood donor typing problems caused by B(A) alleles,a serologic and
molecular study of nine unrelated Chinese individuals and three
families carrying B(A) alleles was conducted. Allele B(A)02 with a
700C>G mutation, allele B(A)04 with a single 640A>G substitution,
and allele B(A)05 with a 641T>C mutation were detected in
multigenerational families and unrelated blood donors. Neither the
B(A)01 nor B(A)03 alleles with 703A>G substitutions were
observed in this study. In addition, a polymerase chain reaction
with a sequence-specific primer genotyping assay was developed
for rapid identification of B(A)02, B(A)04, and B(A)05 alleles using
genomic DNA samples. Immunohematology 2007;23:69–74.
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Owing to the naturally overlapping substrate
specificities of the A and B glycosyltransferases, the
presence of small amounts of A antigen on certain B
group RBCs was observed in the 1980s by using certain
highly potent monoclonal anti-A reagents; these were
designated as the B(A) phenotype.1–4 The B(A)
phenotype is attributable to specific mutations in the B
gene that cause the B transferase to synthesize small
amounts of A antigen. B(A) individuals carry normal B
antigens and a small amount of A antigens on their
RBCs,whereas their sera contain anti-A. The molecular
basis of the first B(A) phenotype was determined by
Yamamoto et al.5 To date, five B(A) alleles (ABO*
B(A)01, B(A)02, B(A)03, B(A)04, and B(A)05) have
been defined by nucleotide sequences according to the
Blood Group Antigen Gene Mutation Database (http://
www.ncbi.nlm.nih.gov). Compared with B101 alleles,
the B(A)01 allele has one silent substitution (657T>C)
and one replacement substitution (703A>G), resulting
in an amino acid change from serine to glycine at
amino acid position 235. The B(A)02 allele was
originally identified in an Asian individual with a single
700C>G substitution, which predicts the alteration of
proline to alanine at position 234.6 The allele B(A)03
differs from B(A)01 by only a single silent substitution
of 657C>T.7 Both the alleles B(A)04 and B(A)05 were
recently found in Chinese populations with 640A>G
and 641T>C substitutions, respectively.8–10 A further
analysis of B(A) phenotype found in Chinese individ-
uals was carried out. This study involved nine
unrelated AweakB phenotype blood donors who had
ambiguous ABO typing results. The study was then
extended to three families, followed by identification of
three B(A) alleles:B(A)02, B(A)04, and B(A)05.
Materials and Methods
Sample collection
Nine B(A) samples were collected from unrelated
individuals from 2000 to 2005. Five individuals carried
the B(A)02 allele, three carried the B(A)04 allele, and
one carried the B(A)05 allele. Three samples were
obtained from Shanghai city, two from Zhejiang
province, and the other four from Sichuan, Fujian,
Anhui, and Henan provinces, respectively.
Serologic studies and DNA-based ABO genotyping
Peripheral blood samples were collected using
ACD anticoagulant tubes. The participants in this study
were all Chinese, and informed consent was obtained.
Serologic characteristics were determined by use of
hemagglutination and adsorption and elution methods,
according to the AABB Technical Manual, with the
exception of reverse ABO grouping.11 In our reverse
ABO grouping,1 drop of plasma instead of 2 to 3 drops
of serum was added to each tube. The reagents used
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for this study were murine monoclonal anti-A (BIRMA-
1), anti-B (LB-2), and anti-A,B (ES4+ES15; Serological
Corporation, Livingston, UK) and human polyclonal
anti-A, anti-B, and anti-A,B (Blood Reference Laboratory,
Shanghai, China), in addition to anti-A1 (Dolichos
biflorus) and anti-H (Ulex europaeus) lectins (Gamma
Biologicals Inc., Houston, TX). Genomic DNA was
prepared from whole blood using a DNA blood mini kit
(QIAamp, Qiagen, Hilden, Germany). Preliminary
genotyping for A101, A2, B, and O alleles was carried
out using the duplex polymerase chain reaction-
restriction fragment length polymorphism (PCR–RFLP)
method, which allows detection of single-nucleotide
polymorphisms (SNP) at nucleotide (nt) 261, nt 467, nt
703, and nt 1096, as described by Olsson and Chester.12
In brief, a 252-base pair (bp) fragment of exon 6 and an
843-bp fragment of exon 7 were amplified by PCR in
the same tube using primer pairs mo57/mo46 and
mo101/mo71 (Table 1). Each PCR reaction was carried
out with a final volume of 25 µL containing 2.5 µL of
PCR buffer, 20 mM MgCl2, 0.2 mM dNTP, 1 U Pfu DNA
polymerase (Bio Basic Inc., Markham Ontario, Canada),
0.2 µM primers, 10% (vol/vol) glycerol, and 50 ng of
genomic DNA. After denaturation for 10 minutes at
95°C, samples were subjected to 35 cycles of PCR in a
DNA thermal cycler (GeneAmp PCR System 9700,
Applied Biosystems,Foster City,CA). The first 10 cycles
consisted of 94°C for 60 seconds, 63°C for 90 seconds,
and 72°C for 60 seconds. The remaining 25 cycles
consisted of 94°C for 60 seconds, 61°C for 90 seconds,
and 72°C for 60 seconds followed by a final extension
at 72°C for 10 minutes. Ten microliters of PCR product
was digested with KpnI and MspI at 37ºC for 2 hours
according to the manufacturer’s protocols (New
England Biolabs, Ipswich, MA). Then, 7 µL of the
digestion mixes was separated electrophoretically for
1.5 hours at 150 V on 12% nondenatured polyacryl-
amide gels. The gel was stained using ethidium
bromide.
Cloning and sequencing
The entire exons 6 and 7 of the ABO gene were
amplified by PCR using two pairs of primer,
mo57/mo46 and mo101/mo71, respectively. The blunt-
end PCR products of Pfu DNA polymerase were
purified using a gel extraction kit (Qiagen). Adenine
tails were added artificially. The PCR products were
cloned into pGEM-T easy vector (Promega, Madison,
WI), and then transformed into competent DH5α E.
coli. After transformation, four to six colonies were
randomly selected, and plasmid DNA was extracted
using Wizard Minipreps’ DNA purification system
(Promega). For each sample, at least two positive
clones were sequenced with a BigDye Terminator
Cycle Sequencing kit on an ABI PRISM 3700 DNA
Analyzer (Applied Biosystems).
PCR-SSP genotyping
An easy polymerase chain reaction with a
sequence-specific primer (PCR-SSP) assay was
developed to detect SNP at nt 640, nt 641, and nt 700.
This approach relies on the sequences of the primers
used in the PCR. When the 3′ nucleotide of a primer
perfectly matches the sequence at the site of a given
allele, the sample DNA, as a template for PCR, will be
amplified. However, when the 3′ nucleotide of the
primer is mismatched, amplification will not occur. For
the detection of each allele, two pairs of primers are
included in the PCR mixes; one is an allele-specific
primer to amplify a specific allele and the other is a
common primer to amplify a common gene to control
the efficiency of the PCR. The sequence-specific
oligonucleotide primers were designed according to
published sequence data (Table 1). Six PCR-SSP mixes
(B640A, B640G, B641T, B641C, B700C, and B700G)
were prepared, to detect nt 640A, nt 640G, nt 641T, nt
641C, nt 700C, and nt 700G, respectively. Control
primers that amplified a 427-bp fragment of the human
growth hormone (HGH) gene were included in all
reactions. The initial PCR was carried out with 1 µL of
purified DNA sample (0.05 to 0.10 µg), 1 µL of diluted
Taq polymerase (0.25–0.33 U),and 8 µL of PCR mix (10
mM Tris-HC1 [pH 8.3], 50 mM KCl, 1.5 mM MgCl2,
0.001% [wt/vol] gelatin, 0.2 mM dNTPs, 0.5 µM of each
forward and reverse primer, 0.2 µM of each internal
control primer) in a final 10-µL reaction volume. After
denaturation for 5 minutes at 95°C, samples were
subjected to 30 cycles of PCR in a DNA thermal cycler.
Each cycle consisted of 95°C for 30 seconds, 60°C for
30 seconds, and 72°C for 1.5 minutes, followed by a
final extension at 72°C for 5 minutes. PCR products
were analyzed by electrophoresis on a 2% agarose gel
containing 0.5 µg of ethidium bromide/mL and visual-
ized with ultraviolet transillumination.
Classification and nomenclature
The ABO allele names used in this paper conform
to the unofficial nomenclature used in the Blood
Group Antigen Gene Mutation Database.13
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Table 1. Primers used for B(A) blood group genotyping by PCR-SSP
Primers: PCR product
Primer* Sequence (5′-3′) Nucleotide position GenBank accession no. size (bp)
mo57(F) CGGGATCCATGTGGGTGGCACCCTGCCA 20069–20089 AY268591 mo57/mo46:252
mo46(R) CGGAATTCACTCGCCACTGCCTGGGTCTC 20286–20308 AY268591
mo101(F) CGGGATCCCCGTCCGCCTGCCTTGCAG 21292–21311 AY268591 mo101/mo71:843
mo71(R) GGGCCTAGGCTTCAGTTACTC 22108–22127 AY268591
640A(F) GTGTGCGTGGACGTGGACA 622–640 AF134412 640A/703A:100
640G(F) GTGTGCGTGGACGTGGACG 248–266 DQ124679 640G/703A:100
641T(F) TGTGCGTGGACGTGGACAT 623–641 AF134412 641T/703A:99
641C(F) TGTGCGTGGACGTGGACAC 249–267 DQ124678 641C/703A:99
703A(R) GGCTGCTTCCGTAGAAGCT 6142–6160 AJ536135
526G(F) CTGTCAGTGCTGGAGGTGG 893–912 AJ536135
700C(R) TGCTTCCGTAGAAGCTGGG 1319–1298 F134412 526G/700C:215
700G(R) TGCTTCCGTAGAAGCTGGC 526G/700G:215
HGH(F) GCCTTCCCAACCATTCCCTT 5947–5965 M13438
HGH(R) TCACGGATTTCTGTTGTGTTTC 700–718 M13438 HGHF/HGHR:427
*(F) indicates forward primer; (R), reverse primer. Primers mo57,mo46,mo101, and mo71 were prepared according to Olsson and Chester, 1995. The sequences underlined are
artificial. Primer 700G was modified from the primer originally reported byYu et al.6 Primer pair 640A/703A detects nt 640A and nt 703A; 640G/703A detects nt 640G and nt
703A; 641T/703A detects nt 641T and nt 703A; 641C/703A detects nt 641C and nt 703A; 526G/700C detects nt 526G and nt 700C; 526G/700G detects nt 526G and 700G.
Table 2. Serologic characteristics and genotypes of B(A) phenotype
Reaction of RBCs with Reaction of plasma with
Samples* Phenotype Genotype Anti-A Anti-B Anti-A,B Anti-A1 Anti-H A Cells B Cells O Cells
Family A
1 B† B(A)04/B 0 12 12 0 5 5 0 0
2 O† O/O 0 0 NT NT 10 8 10 0
3 B† B/O 0 12 12 0 5 8 0 0
4 B(A) B(A)04/O 8 12 12 0 8 8 0 0
5 B(A) B(A)04/O 5 12 12 0 8 8 0 0
6 A A/O 12 0 NT NT 8 0 12 0
7 B(A) B(A)04/O 8 12 12 0 10 8 0 0
Family B
1 B(A)† B(A)05/O 5 12 12 NT 10 5 0 0
2 O† O/O 0 0 NT NT 12 8 8 0
3 B(A) B(A)05/O 8 12 12 0 12 8 0 0
4 B(A) B(A)05/O 8 12 12 0 12 8 0 0
5 B(A)† B(A)05/O 5 12 NT NT 8 NT NT NT
Family C
1 O† O/O 0 0 NT 0 12 10 10 0
2 B† B(A)02/B 0 12 NT 0 5 10 0 0
3 B(A) B(A)02/O 8 12 NT 0 8 8 0 0
4 B(A) B(A)02/O 8 12 NT 0 8 10 0 0
5 B B/O 0 12 NT 0 5 10 0 0
6 B(A) B(A)02/O 10 12 NT 0 8 8 0 0
7 B B/O 0 12 NT 0 5 8 0 0
8 B(A) B(A)02/O 8 12 NT 0 8 8 0 0
Unrelated
1 B(A) B(A)02/O 10 12 NT 0 12 8 0 0
2 B(A) B(A)02/O 10 12 NT 0 12 8 0 0
3 B(A) B(A)02/O 12 12 NT 0 12 10 0 0
4 B(A) B(A)02/O 12 12 NT 0 8 10 0 0
5 B(A) B(A)04/O 8 12 12 0 12 12 0 0
6 B(A) B(A)04/O 5 12 12 0 12 12 0 0
*Sample numbers are the same as used in Figure 2.
† No. 5 in family B is a baby.All others marked with dagger are older than 60 years of age.
NT = not tested.
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Results and Discussion
Some monoclonal anti-A reagents used in our
routine donor blood grouping are capable of
agglutinating B(A) RBCs; therefore, this results in a
discrepancy between RBC (forward) and plasma
(reverse) ABO grouping. In Table 2, a discrepancy
between the forward and reverse ABO grouping was
observed in nine blood donors (Family A No. 7, Family
B No. 4, Family C No. 6, and six unrelated individuals
from No. 1 to No. 6). B(A) RBCs showed a trace
reaction with human polyclonal anti-A and stronger
agglutination with murine monoclonal anti-A. Some
samples carrying the B(A)02 allele scored as high as 12
when they were reacted with monoclonal anti-A. In
addition, these sera contained only anti-A antibody. Our
observation is in concordance with the study
performed byYu et al.6 The presence of A antigens on
the RBCs was confirmed by adsorption and elution
methods, whereas only B and H substances were
detected in their saliva (data not shown). The
phenotype could be serologically distinct from classic
cis-AB. In classic cis-AB, the B antigen on RBCs is
weakly expressed, and most of them are represented
serologically by A2B3.
14 The preliminary genotypes of
all nine B(A) donors were B/O heterozygous,
Fig. 1. Sequencing chromatograms. The region from codon 212 to 215
(number on top) in exon 7 of B101, B(A)04, and B(A)05 alleles
is shown. The arrows indicate the position for nucleotide 640
and 641, respectively.
Fig. 2. Family pedigree and detection of SNP by PCR-SSP assay. The
arrows indicate the propositi. ABO genotypes are noted in the
symbols. Filled squares and circles represent B(A)02, B(A)04, or
B(A)05 allele carriers; open squares and circles indicate those
family members who do not carry the B(A) alleles; NT = not
tested; / = deceased. The numbers used for the family members
are the same as those used on the gel electrophoretogram. Lane
M shows a 100-bp DNA ladder. The top band is the housekeeping
gene (HGH) as an internal positive control. (A) Segregation and
inheritance of B(A)04 allele in family A. Genotypes at nt 640
were determined by two PCR mixes, B640A and B640G, in two
separate PCR amplifications. (B) Inheritance of B(A)05 allele in
family B. Two PCR mixes, B641T and B641C, were used in two
separate PCR amplifications to determine genotypes at nt 641.
An unrelated donor with genotype B101/B101 was used
(number 6 on the gel) as a positive control for PCR mix B641T.
(C) Segregation and inheritance of B(A)02 allele in family C. Two
PCR mixes, B700C and B700G, were used in two separate PCR
amplifications to determine genotypes at nt 700.
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determined by performing a PCR–RFLP genotyping
assay (Table 2).
The genotypes of the family propositi were
determined using sequence analysis. Exons 6 and 7 of
the ABO gene were cloned and then sequenced in both
forward and reverse directions. Nucleotide sequence
alignment revealed that the exon 7 sequence of donor
No. 7 in family A differs from the B101 allele by a
single 640A>G substitution,which changes codon 214
from methionine to valine (ATG → GTG; Figure 1).
Sequence analysis of another donor (No. 4 in family B)
indicated a single 641T>C substitution in exon 7 of
ABO gene,which results in an amino acid replacement
of methionine by threonine at codon 214 (ATG →
ACG;Figure 1). Donor No. 6 (in family C) was found to
carry a 700C>G mutation that had been reported
previously as the B(A)02 allele byYu et al.6
B(A) alleles with 640A>G or 641T>C mutations
were designated as B(A)04 and B(A)05, respectively.
Family studies indicated that both the B(A)04 and
B(A)05 alleles were inherited as expected (Figure 2).
The nucleotide sequences of these two alleles have
been deposited in GenBank with accession number
DQ124679 for B(A)04 and DQ124678 for B(A)05,
respectively. To rapidly detect B(A)02, B(A)04, and
B(A)05 alleles using genomic DNA, an easy PCR-SSP
method was developed. As shown in Figure 2, six
possible genotypes at nt 640, nt 641, and nt 700 could
be clearly distinguished from each other. To check the
reliability and specificity of the typing
method, a total of 34 DNA samples,
including 19 B(A), 5 A, 5 B, and 5 O
phenotypes,were repeatedly tested and a
concordance rate of 100 percent was
observed. In addition, the validity of this
method was verified by sequence
analysis.
Most ABO variants arise from
mutations in exons 6 and 7 of the ABO
gene. The products of A and B genes
differ by four amino acid substitutions at
176, 235, 266, and 268. It was thought
that the amino acid residues at these four
positions were critical for determination
of the specificities of the A and B
glycosyltransferase, and that an over-
lapping specificity results in the
formation of B(A) phenotype.5,14 Both
the B(A)01 and B(A)03 alleles have a
Ser235Gly substitution, whereas the
B(A)02 allele encodes a Pro234Ala
substitution just before position Ser235. As shown in
Figure 3, the B(A)04 and B(A)05 alleles encode a
Met214Val and a Met214Thr substitution, respectively,
at the same position 214. This suggests that the residue
at 214 might also be involved in the determination of
the enzyme specificity.
Acknowledgments
This work was supported by a grant (No.
02ZB14087) from the Shanghai Natural Science
Foundation. We are grateful to Li-Yang Xie and Jing Li
for collecting blood samples from the B(A) families.
References
1. Beck ML, Hardman JT, Henry R. Reactivity of a
licensed murine monoclonal anti-A reagent with
group B cells (abstract).Transfusion 1986; 26:572.
2. Beck ML, Yates AD, Hardman JT, et al.
Consequences of overlapping substrate specificity
of glycosyltransferases (abstract). Transfusion
1987; 27:535.
3. Goldstein J, Lenny L, Hurst, et al. Direct evidence
for the presence of A antigen on group B
erythrocytes. Blood 1987;70(Suppl. 1):109a.
4. Goldstein J, Lenny L, Davies D, et al. Further
evidence for the presence of A antigen on group
B erythrocytes through the use of specific
exoglycosidases.Vox Sang 1989;57:142–6.
Fig. 3. Variation of nucleotides and deduced amino acid in exon 6 and exon 7 of ABO gene.
Dagger signifies allele nomenclature according to Blood Group Antigen Gene
Mutation Database.13 The letter marked with an asterisk indicates silent substitution.
74 I M M U N O H E M A T O L O G Y, V O L U M E 2 3 , N U M B E R 2 , 2 0 0 7
Z.H. GUO ET AL.
5. Yamamoto F, McNeill PD, Yamamoto M, et al.
Molecular genetic analysis of the ABO blood
group system: 3. A(X) and B(A) alleles. Vox Sang
1993; 64:171–4.
6. Yu LC, Lee HL, Chan YS, et al.The molecular basis
for the B(A) allele: an amino acid alteration in the
human histoblood group B alpha-(1,3)-
galactosyltransferase increases its intrinsic alpha-
(1,3)-N-acetylgalactosaminyl transferase activity.
Biochem Biophys Res Commun 1999;262:487–93.
7. Seltsam A, Hallensleben M, Kollmann A, et al.
Systematic analysis of the ABO gene diversity
within exons 6 and 7 by PCR screening reveals
new ABO alleles.Transfusion 2003;43:428–39.
8. Guo ZH,Xiang D,Zhu ZY,et al.Molecular study on
CisAB and B(A) in China (Abstract). Vox Sang
2004;87(Suppl 3):81.
9. Guo ZH,Xiang D,Zhu ZY,et al.Novel B(A)640 and
B(A)641 alleles detected in Chinese individuals
(Abstract).Vox Sang 2005;89(Suppl 2):24.
10. Deng ZH, Yu Q,Wu GG, et al. Molecular genetic
analysis for Ax phenotype of the ABO blood group
system in Chinese.Vox Sang 2005; 89:251–6.
11. Brecher ME.ABO,H, and Lewis Blood Groups and
structurally related antigens In: Brecher ME,AABB
Technical manual. 14th ed. Bethesda, MD:
American Association of Blood Banks, 2002:282.
12. Olsson ML, Chester MA. A rapid and simple ABO
genotype screening method using a novel
B/O2 versus A/O2 discriminating nucleotide
substitution at the ABO locus. Vox Sang 1995;
69:242–7.
13. Blumenfeld OO, Patnaik SK.Allelic genes of blood
group antigens: a source of human mutations and
cSNPs documented in the Blood Group Antigen
Gene Mutation Database. Human Mutation 2004;
23:8–16.
14. Daniels G.ABO,Hh, and Lewis systems. In:Daniels
G, Human blood groups 2nd ed. Oxford, UK:
Blackwell Scientific, 2002:40–1.
Zhong-Hui Guo, MS (corresponding author), Dong
Xiang, BS, Zi-Yan Zhu, BS, Xi Liu, He-Ping Chen, and
Jian-Lian Wang, BS, Blood Group Reference Lab,
Shanghai Blood Center, 1191 Hong Qiao Road,
Shanghai 200051, P. R. China; Da-Zhuang Liu, BS,
Shanghai Transfusion Institute, Shanghai Blood
Center, Shanghai, P. R. China; Tong-Mao Zhao, PhD,
NIAID, National Institutes of Health, Bethesda, MD,
USA.
IMMUNOHEMATOLOGY IS ON THE WEB!
www.redcross.org/pubs/immuno
For more information or to send an e-mail
message “To the editor”
immuno@usa.redcross.org
Notice to Readers: Immunohematology, Journal
of Blood Group Serology and Education, is
printed on acid-free paper.
Attention: State Blood Bank Meeting Organizers
If you are planning a state meeting and would like copies of Immunohematology for distribution, please
contact Cindy Flickinger,Managing Editor, 4 months in advance, by fax or e-mail at (215) 451-2538 or
flickingerc@usa.redcross.org.
